These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1295722)

  • 1. Activity of vancomycin against recently isolated nosocomial gram-positive cocci.
    Maccanti O; Bonadio M
    Drugs Exp Clin Res; 1992; 18(7):295-7. PubMed ID: 1295722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
    Li JT; Li Y; Wang J;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT; Liao CH; Teng LJ; Hsueh PR
    Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].
    Kayaokay Y; Hasçelik G; Gür D; Akalin E
    Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004).
    Jones RN; Stilwell MG; Sader HS; Fritsche TR; Goldstein BP
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):149-53. PubMed ID: 16426793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
    Bezian MC; Ribou G; Masquelier B
    Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surveillance of gram positive cocci susceptibility to betalactams, glycopeptides, and other antimicrobials].
    Giglio MS; Farías O; Lafourcade M; Pinto ME
    Rev Med Chil; 1999 Aug; 127(8):919-25. PubMed ID: 10752252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006).
    Castanheira M; Jones RN; Sader HS
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):235-9. PubMed ID: 18314293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial bloodstream infections: organisms, risk factors, and implications.
    Karchmer AW
    Clin Infect Dis; 2000 Sep; 31 Suppl 4():S139-43. PubMed ID: 11017863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nosocomial catheter-related sepsis secondary to central venous catheters].
    Wu H; Wu Z; Jin D; Xu J
    Zhonghua Wai Ke Za Zhi; 1999 Nov; 37(11):651-3. PubMed ID: 11829916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial spectrum and antibiotic susceptibility profile of gram-positive aerobic bacteria isolated from cancer patients.
    Ashour HM; el-Sharif A
    J Clin Oncol; 2007 Dec; 25(36):5763-9. PubMed ID: 18089873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
    Streit JM; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):307-10. PubMed ID: 15922534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece.
    Malli E; Spiliopoulou I; Kolonitsiou F; Klapsa D; Giannitsioti E; Pantelidi K; Pratti A; Panopoulou M; Grapsa S; Alepopoulou E; Neonakis I; Frantzidou F; Alexiou-Daniel S; Bakola D; Koutsia-Carouzou C; Malamou-Lada H; Zerva L; Vlahaki E; Kartali-Ktenidou S; Anastassiou ED; Petinaki E
    Int J Antimicrob Agents; 2008 Dec; 32(6):525-8. PubMed ID: 18774268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.
    Zhanel GG; DeCorby M; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; Mulvey MR; Hoban DJ;
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):67-80. PubMed ID: 18513913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the antimicrobial resistance patterns of gram-positive cocci isolated from community-private and university-affiliated hospitals from Puerto Rico.
    Vázquez GJ; Robledo IE; Arroyo A; Nadal E; Rodríguez R; Bermudez M; Colón M
    P R Health Sci J; 2003 Jun; 22(2):131-6. PubMed ID: 12866136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    Lin DF; Zhang YY; Wu JF; Wang F; Zheng JC; Miao JZ; Zheng LY; Sheng RY; Zhou X; Shen HH; Ijzerman MM; Croos-Dabrera RV; Sheng W
    Int J Antimicrob Agents; 2008 Sep; 32(3):241-9. PubMed ID: 18635341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitroimidazole resistance genes (nimB) in anaerobic Gram-positive cocci (previously Peptostreptococcus spp.).
    Theron MM; Janse Van Rensburg MN; Chalkley LJ
    J Antimicrob Chemother; 2004 Jul; 54(1):240-2. PubMed ID: 15150170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drugs for Gram-positive uropathogens.
    Wagenlehner FM; Naber KG
    Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S39-43. PubMed ID: 15364305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gram-positive, catalase negative cocci isolated from clinical material--identification and drug sensitivity of strains].
    Rokosz A; Rafałowska K; Lipnicki D
    Przegl Epidemiol; 1996; 50(3):265-72. PubMed ID: 8927737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.